The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030

The global digital biomarkers market is projected to be worth over USD 22 billion by 2030, growing at a CAGR of 35.74%, claims Roots Analysis

The “Digital Solutions for Biomarkers Market by Content of Solution (Standalone Software Solutions and Combination Offerings), Purpose of Solution (Diagnosis, Early Screening, Monitoring, and Predictive Insights), Type of Biomarker (Cognitive, Idiosyncrat...

The global digital biomarkers market is projected to be worth over USD 22 billion by 2030, predicts Roots Analysis

Presently, over 30 players are engaged in the development of digital solutions for different types of biomarkers; these solutions can be analyzed in silico, for a variety of diseases / clinical conditions

The global digital biomarkers market is projected to be worth over USD 22 billion by 2030, growing at a CAGR of 35.74%, claims Roots Analysis

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

The “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely future evolution in this industry over the next ten years

The “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.

More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts

the antibody discovery platforms market is anticipated to be worth close to USD 6 billion by 2030, predicts Roots Analysis

The antibody discovery services and platforms market is projected to grow at an annualized rate of ~10%, till 2030